Allulose

Allulose is a rare sugar with minimal glycemic impact and no artificial synthesis concerns like other sweeteners. However, it is not a food available to Paleolithic humans and long-term safety data remains limited. Some paleo practitioners accept it; others prefer whole-food sweetening sources.

iRobb Wolf and some modern paleo advocates accept allulose as a reasonable occasional sweetener due to its metabolic profile, while stricter interpretations (Cordain) would exclude all refined sweeteners regardless of glycemic impact.

Allulose is a rare sugar with minimal glycemic impact and negligible calories. While not a traditional Mediterranean ingredient, it doesn't contradict core principles as it's minimally processed relative to other sweeteners. However, Mediterranean diet emphasizes whole foods and natural sweetness from fruits rather than sugar substitutes.

iSome Mediterranean diet practitioners accept allulose as compatible because it doesn't spike blood glucose and has minimal metabolic impact, similar to accepting small amounts of honey or fruit-based sweetness.

Allulose is a rare sugar derived from corn or fructose through enzymatic conversion, resulting in an animal-adjacent processed sweetener. While not plant-derived in final form, its origin and processing create debate within the community.

iStrict carnivores following the Lion Diet avoid all sweeteners including allulose. Saladino and Baker have expressed caution about sweetener dependency regardless of source. Some practitioners accept it as a minimal-impact alternative.

Allulose is a rare sugar with minimal glycemic impact and ~90% caloric reduction vs sucrose. DASH guidelines don't explicitly address it, but it avoids added sugars concern. However, long-term safety data is limited, and some GI effects reported at higher intakes.

iNIH DASH guidelines emphasize limiting added sugars broadly; updated clinical interpretation increasingly recognizes allulose as acceptable due to negligible glycemic response and lack of metabolic harm in emerging studies.

Allulose is a rare sugar with minimal glycemic impact (~0.2 GI) and low caloric content (~0.4 cal/g). Dr. Sears' published materials predate allulose's widespread availability. It does not spike insulin like sucrose, but Zone philosophy emphasizes whole foods over sugar substitutes.

iModern Zone practitioners increasingly accept allulose as a low-glycemic sweetener compatible with Zone principles due to its negligible insulin response and minimal caloric impact. Dr. Sears' anti-processed-food stance may conflict with its synthetic origin.

Allulose is a rare sugar with minimal glycemic impact and some prebiotic properties. Emerging research suggests neutral to slightly beneficial inflammatory profile. However, long-term human studies are limited. Generally recognized as safe but newer than established sweeteners.

iSome functional medicine practitioners prefer established anti-inflammatory sweeteners like stevia or monk fruit due to longer safety history. Mainstream nutrition accepts allulose as safe based on available evidence, though more long-term data would strengthen confidence.